Titan Pharmaceuticals
TTNP
#11035
Rank
NZ$10.88 M
Marketcap
NZ$8.18
Share price
-3.76%
Change (1 day)
18.45%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$8.36 Million, an increase over its 2023 earnings that were of -NZ$9.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-43.42%
2024 -NZ$8.36 Million-15.5%
2023 -NZ$9.89 Million-45.43%
2022 -NZ$18.12 Million16.29%
2021 -NZ$15.59 Million-907.36%
2020 NZ$1.92 M-106.6%
2019 -NZ$29.22 Million82.4%
2018 -NZ$16.02 Million-36.93%
2017 -NZ$25.41 Million-378.62%
2016 NZ$9.11 M-145.53%
2015 -NZ$20.03 Million369.37%
2014 -NZ$4.27 Million-125.9%
2013 NZ$16.47 M-177.74%
2012 -NZ$21.19 Million13.59%
2011 -NZ$18.66 Million74.37%
2010 -NZ$10.7 Million3.61%
2009 -NZ$10.33 Million
2007 -NZ$32.73 Million12.08%
2006 -NZ$29.21 Million-28.65%
2005 -NZ$40.93 Million-10.03%
2004 -NZ$45.49 Million-6.08%
2003 -NZ$48.44 Million-14.76%
2002 -NZ$56.82 Million32.52%
2001 -NZ$42.88 Million27.55%
2000 -NZ$33.62 Million62.5%
1999 -NZ$20.69 Million4.04%
1998 -NZ$19.89 Million49.33%
1997 -NZ$13.32 Million-27.88%
1996 -NZ$18.47 Million13.04%
1995 -NZ$16.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.52 B-934,431.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.55 B-553,468.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-NZ$0.33 Billion 6,519.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-2,748.84%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.09 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.58 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA